What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?

The ticker symbol for Madrigal Pharmaceuticals, Inc. is NASDAQ:MDGL

Does Madrigal Pharmaceuticals, Inc. pay dividends?

No, Madrigal Pharmaceuticals, Inc. does not pay dividends

What sector is Madrigal Pharmaceuticals, Inc. in?

Madrigal Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Madrigal Pharmaceuticals, Inc. in?

Madrigal Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Madrigal Pharmaceuticals, Inc. based in?

Madrigal Pharmaceuticals, Inc. is headquartered in United States

When did Madrigal Pharmaceuticals, Inc. go public?

Madrigal Pharmaceuticals, Inc. initial public offering (IPO) was on February 6, 2007

Is Madrigal Pharmaceuticals, Inc. in the S&P 500?

No, Madrigal Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?

No, Madrigal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?

No, Madrigal Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Madrigal Pharmaceuticals, Inc. last earnings report?

Madrigal Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026

When does Madrigal Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Madrigal Pharmaceuticals, Inc. is November 4, 2026

MDGL Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, MDGL price is $507.37, down -5.38% on August 13, 2026
Current Price All-Time High: MDGL price is currently -17.50% below its historical high of $615.00 set on December 24, 2025
Market Cap: MDGL current market cap is $12B, up +42.05% over the past 365 days
Revenue: MDGL current annual revenue is $958.40M, up +432.05% year-over-year
Next Earnings: The next earnings release for MDGL is on November 4, 2026

Profile

Company profile for Madrigal Pharmaceuticals, Inc. (MDGL)
Metric	Value
Full Name	Madrigal Pharmaceuticals, Inc.
Ticker	NASDAQ: MDGL
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Feb 6, 2007
Indexes	Not included
Website	madrigalpharma.com
Employees	528

Key Metrics

Madrigal Pharmaceuticals, Inc. Key Details
Metric	Value	Date
Price	$507.37	Aug 13, 26
Price, 1D Change	-5.38%	Aug 13, 26
Market Cap	$12B	Aug 13, 26
	-	Aug 13, 26
PE Ratio	-	Aug 13, 26
Beta	0.33	Aug 13, 26
Revenue	$958.40M	Dec 31, 25
Revenue, 1Y Change	+432.05%	Dec 31, 25
EPS	-$12.85	Dec 31, 25
EPS, 1Y Change	+41.33%	Dec 31, 25

Events

Madrigal Pharmaceuticals, Inc. Events
Metric	Value	Date
Next Earnings		Nov 4, 26
Last Qtr. Earnings		Jul 30, 26
Last Ann. Earnings		Feb 19, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	1:35	Jul 25, 16
Next Split	N/A	N/A
Last Ticker Change	SNTA	Jul 25, 16
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

MDGL Estimates
Metric	Value	Date
EPS	-$12.85	Dec 31, 25
EPS Estimate	-$6.49	N/A
EPS Est. Change	+49.48%	N/A
Revenue	$958.40M	Dec 31, 25
Revenue Estimate	$1.53B	N/A
Revenue Est. Change	+59.25%	N/A
Current Price	$507.37	Aug 13, 26
Price Target	$651.50	-
Price Tgt. Change	+28.41%	-

🔒 Log In To Unlock Full Data

EPS

MDGL EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$23.47	-$21.90	+6.69%
2025	-$11.43	-$12.85	-12.39%
2026	-$6.49	N/A	+49.48%
2027	$9.63	N/A	+174.90%

Revenue

MDGL revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$174.49M	$180.13M	+3.23%
2025	$949.73M	$958.40M	+0.91%
2026	$1.53B	N/A	+59.25%
2027	$2.14B	N/A	+123.80%

🔒 Log In To Unlock Full Data

Performance

MDGL Performance
Metric	Value	Date
Price, 1Y	+36.62%	Aug 13, 26
Price, 3Y	+192.53%	Aug 13, 26
Market Cap, 1Y	+42.05%	Aug 13, 26
Market Cap, 3Y	+266.15%	Aug 13, 26
Revenue, 1Y	+432.05%	Dec 31, 25
Revenue, 3Y	+100.00%	Dec 31, 25
EPS, 1Y	+41.33%	Dec 31, 25
EPS, 3Y	+25.44%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

MDGL Technical Indicators
Metric	Value	Date
Current Price	$507.37	Aug 13, 26
SMA 200	$510.92	Aug 13, 26
SMA 50	$517.84	Aug 13, 26
EMA 200	$490.17	Aug 13, 26
EMA 50	$519.62	Aug 13, 26
MACD	-$2.63	Aug 13, 26
Beta	0.33	Aug 13, 26
ATR	$24.06	Aug 13, 26
14-Day RSI	45.81	Aug 13, 26
10-Day Volatility	55.84%	Aug 13, 26

Dividends

MDGL Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Aug 13, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

MDGL Income & Profitability
Metric	Value	Date
Revenue	$958.40M	Dec 31, 25
EPS	-$12.85	Dec 31, 25
Gross Profit	$900.75M	Dec 31, 25
Gross Margin	93.98%	Dec 31, 25
Operating Income	-$300.10M	Dec 31, 25
Operating Margin	-31.31%	Dec 31, 25
Net Income	-$288.28M	Dec 31, 25
Net Margin	-30.08%	Dec 31, 25
EBITDA	-$298.59M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

MDGL Financial Health
Metric	Value	Date
Debt To Equity	0.58	Dec 31, 25
	4.01	Dec 31, 25
	3.77	Dec 31, 25
	-	Dec 31, 25
	2	Jun 30, 26
	9.25	Aug 13, 26

Valuations

MDGL Valuations
Metric	Value	Date
PE Ratio	-	Aug 13, 26
	9.13	Aug 13, 26
	22.38	Aug 13, 26
	-34.98	Aug 13, 26
	-	N/A

Balance Sheet

MDGL Balance Sheet
Metric	Value	Date
Book Value	$602.69M	Dec 31, 25
	$988.65M	Dec 31, 25
	$1.26B	Dec 31, 25
	$1.25B	Dec 31, 25
	$656.90M	Dec 31, 25
	$310.29M	Dec 31, 25
Total Debt	$347.63M	Dec 31, 25
	$1.02M	Dec 31, 25
	$48.88M	Dec 31, 25

Expenses

MDGL Expenses
Metric	Value	Date
	$1.25B	Dec 31, 25
	$1.20B	Dec 31, 25
	$57.65M	Dec 31, 25
	$0.00	Dec 31, 25
	$1.51M	Dec 31, 25
	$0.00	Dec 31, 25
	$0.00	Dec 31, 25

Cash Flow

MDGL Cash Flow
Metric	Value	Date
	-$189.55M	Dec 31, 25
	$32.32M	Dec 31, 25
	$255.98M	Dec 31, 25
Capex	$3.47M	Dec 31, 25
	-$193.02M	Dec 31, 25

Recent analyst updates

MDGL Recent analyst updates
Metric	Value	Date
Wolfe Research	→	Aug 4, 26
Barclays	→	Aug 3, 26
Canaccord Genuity	→	Jul 29, 26
Wells Fargo		Jul 27, 26
B of A Securities	→	Jun 11, 26
Truist Securities	→	May 13, 26
Evercore ISI Group	→	May 7, 26
Canaccord Genuity	→	May 7, 26
HC Wainwright & Co.	→	May 6, 26
B of A Securities	→	Feb 20, 26

Analyst sentiment

Institutional ownership

No data

Screeners with MDGL

FAQ

What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?: The ticker symbol for Madrigal Pharmaceuticals, Inc. is NASDAQ:MDGL
Does Madrigal Pharmaceuticals, Inc. pay dividends?: No, Madrigal Pharmaceuticals, Inc. does not pay dividends
What sector is Madrigal Pharmaceuticals, Inc. in?: Madrigal Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Madrigal Pharmaceuticals, Inc. in?: Madrigal Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Madrigal Pharmaceuticals, Inc. based in?: Madrigal Pharmaceuticals, Inc. is headquartered in United States
When did Madrigal Pharmaceuticals, Inc. go public?: Madrigal Pharmaceuticals, Inc. initial public offering (IPO) was on February 6, 2007
Is Madrigal Pharmaceuticals, Inc. in the S&P 500?: No, Madrigal Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?: No, Madrigal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?: No, Madrigal Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Madrigal Pharmaceuticals, Inc. last earnings report?: Madrigal Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
When does Madrigal Pharmaceuticals, Inc. report earnings?: The next expected earnings date for Madrigal Pharmaceuticals, Inc. is November 4, 2026

Data Sources & References

MDGL Official Website www.madrigalpharma.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl